Literature DB >> 34510911

No-Touch Versus Conventional Vein Harvesting Techniques at 12 Months After Coronary Artery Bypass Grafting Surgery: Multicenter Randomized, Controlled Trial.

Meice Tian1, Xianqiang Wang1, Hansong Sun1, Wei Feng1, Yunhu Song1, Feng Lu1, Liqing Wang1, Yang Wang2, Bo Xu3, Huaibin Wang4, Su Liu5, Zhigang Liu6, Yu Chen7, Qi Miao8, Pixiong Su9, Yan Yang1, Shaoxian Guo1, Bin Lu10, Zhiqiang Sun1, Kaiyang Liu1, Changwei Zhang1, Yue Wu1, Haitao Xu1, Wei Zhao1, Chao Han1, Xingtong Zhou1, Enshi Wang1, Xiaoning Huo1, Shengshou Hu1.   

Abstract

BACKGROUND: Vein graft occlusion is deemed a major challenge in coronary artery bypass grafting. Previous studies implied that the no-touch technique for vein graft harvesting could reduce occlusion rate compared with the conventional approach; however, evidence on the clinical benefit and generalizability of the no-touch technique is scare.
METHODS: From April 2017 to June 2019, we randomly assigned 2655 patients undergoing coronary artery bypass grafting at 7 hospitals in a 1:1 ratio to receive no-touch technique or conventional approach for vein harvesting. The primary outcome was vein graft occlusion on computed tomography angiography at 3 months and the secondary outcomes included 12-month vein graft occlusion, recurrence of angina, and major adverse cardiac and cerebrovascular events. The generalized estimate equation model was used to account for the cluster effect of grafts from the same patient.
RESULTS: During the follow-up, 2533 (96.0%) participants received computed tomography angiography at 3 months after coronary artery bypass grafting and 2434 (92.2%) received it at 12 months. The no-touch group had significantly lower rates of vein graft occlusion than the conventional group both at 3 months (2.8% versus 4.8%; odds ratio, 0.57 [95% CI, 0.41-0.80]; P<0.001) and 12 months (3.7% versus 6.5%; odds ratio, 0.56 [95% CI, 0.41-0.76]; P<0.001). Recurrence of angina was also less common in the no-touch group at 12 months (2.3% versus 4.1%; odds ratio, 0.55 [95% CI, 0.35-0.85]; P<0.01). Rates of major adverse cardiac and cerebrovascular events were of no significant difference between the 2 groups. The no-touch technique was associated with higher rates of leg wound surgical interventions at 3-month follow-up (10.3% versus 4.3%; odds ratio, 2.55 [95% CI, 1.85-3.52]; P<0.001).
CONCLUSIONS: Compared with the conventional vein harvesting approach in coronary artery bypass grafting, the no-touch technique significantly reduced the risk of vein graft occlusion and improved patient prognosis. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03126409.

Entities:  

Keywords:  coronary artery bypass; randomized controlled trial

Mesh:

Year:  2021        PMID: 34510911     DOI: 10.1161/CIRCULATIONAHA.121.055525

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  The "No-touch" Harvesting Technique Revives the Position of the Saphenous Vein as an Important Conduit in CABG Surgery: 30-year Anniversary.

Authors:  Bruno Botelho Pinheiro; Michael Dashwood; Domingos S R Souza
Journal:  Braz J Cardiovasc Surg       Date:  2021-10-17

2.  Commentary: The saphenous vein in coronary artery bypass grafting: Optimizing our workhorse.

Authors:  Max T Buchko; Marc Ruel
Journal:  JTCVS Tech       Date:  2021-10-19

3.  A Single-Cell Survey of Cellular Heterogeneity in Human Great Saphenous Veins.

Authors:  Yiping Sun; Xueqing Hu; Kui Zhang; Man Rao; Pengbin Yin; Ran Dong
Journal:  Cells       Date:  2022-08-31       Impact factor: 7.666

4.  Current intraoperative storage and handling practices of autologous bypass conduit: A survey of the royal australasian college of surgeons.

Authors:  A B Haymet; N Pinto; S Peden; T Cohen; M P Vallely; D McGiffin; R Naidoo; J Jenkins; J Y Suen; J F Fraser
Journal:  Front Surg       Date:  2022-08-26

Review 5.  The Role of Endothelial Cells in the Onset, Development and Modulation of Vein Graft Disease.

Authors:  Shameem S Ladak; Liam W McQueen; Georgia R Layton; Hardeep Aujla; Adewale Adebayo; Mustafa Zakkar
Journal:  Cells       Date:  2022-09-29       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.